American Journal of Cardiology
Volume 103, Issue 3 , Pages 316-321 , 1 February 2009

Comparison of Outcomes and Safety of “Facilitated” Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

Received 30 July 2008 ,Revised 16 September 2008 ,Accepted 16 September 2008.

References 

  1. The ASSENT-4 Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet. 2006;367:569–678
  2. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, et al Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358:2205–2217
  3. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomized trials. Lancet. 2006;367:579–588
  4. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. J Am Coll Cardiol. 2001;38:2114–2130
  5. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76:142–154
  6. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;317;:581–588
  7. The TIMI Study Group. Comparison of invasive and conservative strategies following intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) II Trial. N Engl J Med. 1989;320:618–628
  8. de Bono D. The European cooperative study group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty. J Am Coll Cardiol. 1988;12:20A–23A
  9. Ross AM, Coyne KS, Reiner JS, Greenhouse SW, Fink C, Frey A, et al A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT Trial. J Am Coll Cardiol. 1999;34:1954–1962
  10. Schweiger MJ, Cannon CP, Murphy SA, Gibson CM, Cook JR, Giugliano RP, et al. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol. 2001;88:831–836
  11. Herrman HC, Moliterno DJ, Ohman EM, Stebbins AL, Bode C, Betriu A, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction (Results from the SPEED (GUSTO-4 Pilot) trial). J Am Coll Cardiol. 2000;36:1489–1496
  12. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory (The PRAGUE Study). Eur Heart J. 2000;21:823–831
  13. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 2003;42:634–641
  14. Fernandez-Aviles F. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet. 2004;364:1045–1053
  15. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, et al Combined Angioplasty and Pharmacological Intervention versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study). J Am Coll Cardiol. 2005;46:417–424
  16. Fernandez-Aviles F, Alonso JJ, Pena G, Blanco J, Alonso-Briales J, Lopez-Mesa J, et al. Primary angioplasty versus early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J. 2007;28:949–960
  17. ADVANCE MI Investigators. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated Addressing the Value of facilitated Angioplasty after Combination therapy or Eptifibitide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. Am Heart J. 2005;150:116–122
  18. Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirshinger J, Schmitt C, et al. Early administration of reteplase plus abciximab versus abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled study. JAMA. 2004;291:947–954

PII: S0002-9149(08)01672-X

doi: 10.1016/j.amjcard.2008.09.078

American Journal of Cardiology
Volume 103, Issue 3 , Pages 316-321 , 1 February 2009

Article Tools

* Image Usage & Resolution